Industry Focus

The 21st Century Cures Act ignites innovation with perks to biopharma and medical device makers. Also, Kite Pharma and Novartis prep plans to pitch their CAR-T cancer therapies to the FDA.

Direct download: 20161207_IF_Healthcare.mp3
Category:Podcast -- posted at: 3:30pm EST